Clinical Trials Logo

Filter by:
NCT ID: NCT02997059 Terminated - Clinical trials for Crohn's Disease Aggravated

Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease.

AscaMC
Start date: July 2008
Phase: Phase 2
Study type: Interventional

This was prospective study randomized in two controlled parallel groups verum versus placebo. The objectives were to assess the influence of antifungal treatment with Fluconazole (FCZ) on the rate of ASCA and endoscopic recurrence at 6 months. The rational was based on our previous research having established i) a link between intestinal inflammation and the opportunistic fungal pathogen C. albicans -a yeast colonizing the human digestive tract- ii) the demonstration that this yeast species could be at the origin of ASCA, a prominent serological marker of CD. It was therefore hypothesized that the FCZ could lower the rate of ASCA and/or reduce the occurrence of recurrences.

NCT ID: NCT02994953 Terminated - Clinical trials for Advanced Solid Tumors

A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)

COMBO
Start date: January 31, 2017
Phase: Phase 1
Study type: Interventional

The study consists of 2 parts: Dose Escalation phase (Part A) and Expansion phase (Part B). The dose escalation phase will evaluate the safety, tolerability, and PK of avelumab in combination with M9241 in subjects with locally advanced, unresectable, or metastatic solid tumors. Expansion phase will assess the safety and clinical activity of the combination regimen in selected tumor types. In Expansion phase subjects who have completed the combination treatment of avelumab at a given dose level of M9241, a safety review will be performed by the Safety monitoring committee in order to make a decision on the next dose level. Successive cohorts of 3 to 6 subjects will be treated with escalating doses of M9241 with avelumab intravenous (IV).

NCT ID: NCT02994914 Terminated - Breast Cancer Clinical Trials

GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance

GERABEL
Start date: December 5, 2016
Phase: N/A
Study type: Interventional

This study proposes an onco geriatric evaluation (Activities of Daily Living, Instrumental Activities Of Daily Living, Mini Mental State Examination, mini Geriatric Depression Scale, Mini Nutritional Assessment, Cumulative Illness Rating Scale-Geriatric, and " timed get up and go " tests) for elderly breast cancer patients. The score obtained at this evaluation will determine the radiotherapy scheme.

NCT ID: NCT02994823 Terminated - Clinical trials for Breastfeeding Mothers of Infants Hospitalized

The "Pooling" Expressed Breast Milk: A Method for Improving the Nutritional Intake of Premature Infants

POOL-BM
Start date: June 2015
Phase:
Study type: Observational

The investigators compared a pooled mother's expressed breastmilk for 24 hours with individual pump session collection of milk to provide a more consistent caloric product without increasing bacterial contamination.

NCT ID: NCT02993783 Terminated - Clinical trials for Allogeneic Hematopoietic Stem Cell Transplantation

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Start date: April 28, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the initial activity, tolerability, safety and to identify a recommended dose and regimen of vedolizumab intravenous (IV) administered for treatment of steroid-refractory acute intestinal GvHD in participants who have undergone allo-HSCT.

NCT ID: NCT02992964 Terminated - Clinical trials for Refractory or Recurrent Hypermutated Malignancies

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

Start date: May 15, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open-label, single arm, multi-center, pilot study of Nivolumab in pediatric patients with recurrent or refractory hypermutant malignancies aged 12 months to 18 years of age. This study is to assess clinical and radiological benefits of treatment with Nivolumab in children with hypermutated cancers, including those with bMMRD syndrome. It is our expectation that patients with bMMRD syndrome will account for the majority of patients enrolled on this study.

NCT ID: NCT02992860 Terminated - Clinical trials for Acute Myeloid Leukemia (AML)

Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY

SAMBA
Start date: July 2016
Phase: Phase 2
Study type: Interventional

The outcome of HMA-refractory patients with MDS or AML is dismal with a median survival of 5 months after failure, representing a significant unmet medical need due to the very limited treatment options. In this context, a specific targeting of the leukemic stem cell (LSC) seems a promising option to selectively combat the leukemic progenitor cells. In fact, CD123 is overexpressed in AML and MDS progenitors making it an attractive target for immunotherapy-based approaches. JNJ-56022473 is a promising compound that has been engineered with regard to this strategy and the current phase II trial has the aim to evaluate the overall hematological response rate at 3 months in HMA refractory/relapsed AML and MDS patients.

NCT ID: NCT02992132 Terminated - Clinical trials for Agitation and Aggression in Alzheimer's Disease

Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)

Start date: November 2016
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of pimavanserin compared with placebo in treatment of agitation and aggression after 12 weeks of treatment

NCT ID: NCT02988609 Terminated - Concussion Clinical Trials

Concussion in Rugby Players: a Pilot Study of Neural Recovery Using fMRI

RugbyCom
Start date: September 2016
Phase: N/A
Study type: Interventional

This study assess the putative persistence of neural damage using resting state fMRI after concussion in rugby player once they have clinically recovered. The hypothesis is that despite a clinical recovery (absence of symptoms; neurological and neuropsychological examination returned to normal) connectivity map obtained using resting state fMRI are significantly different from a group of control subjects.

NCT ID: NCT02987660 Terminated - Myopia Clinical Trials

Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMax

Start date: March 3, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare Topography Guided Laser In Situ Keratomileusis (LASIK) corneal surgery to Small Incision Lenticule Extraction (SMILE) corneal surgery for the treatment of myopia with astigmatism.